Published in J Immunol on August 15, 2006
Role for Spi-C in the development of red pulp macrophages and splenic iron homeostasis. Nature (2008) 2.18
Microarray expression analysis and identification of serum biomarkers for Niemann-Pick disease, type C1. Hum Mol Genet (2012) 1.10
Regulation of the interleukin-7 receptor alpha promoter by the Ets transcription factors PU.1 and GA-binding protein in developing B cells. J Biol Chem (2007) 1.06
Reduction in PU.1 activity results in a block to B-cell development, abnormal myeloid proliferation, and neonatal lethality. Exp Hematol (2007) 0.89
Predicting tissue specific transcription factor binding sites. BMC Genomics (2013) 0.80
Transgenic expression of Spi-C impairs B-cell development and function by affecting genes associated with BCR signaling. Eur J Immunol (2008) 0.78
Trichostatin A specifically improves the aberrant expression of transcription factor genes in embryos produced by somatic cell nuclear transfer. Sci Rep (2015) 0.77
Genome-wide comparison of PU.1 and Spi-B binding sites in a mouse B lymphoma cell line. BMC Genomics (2015) 0.76
Essential role of spi-1-like (spi-1l) in zebrafish myeloid cell differentiation. Blood (2009) 0.76
Selection signatures in Canchim beef cattle. J Anim Sci Biotechnol (2016) 0.75
Master transcription factors determine cell-type-specific responses to TGF-β signaling. Cell (2011) 3.94
Cooperative and antagonistic interplay between PU.1 and GATA-2 in the specification of myeloid cell fates. Immunity (2002) 2.99
CHD1 motor protein is required for deposition of histone variant H3.3 into chromatin in vivo. Science (2007) 2.71
CCCTC-binding factor (CTCF) and cohesin influence the genomic architecture of the Igh locus and antisense transcription in pro-B cells. Proc Natl Acad Sci U S A (2011) 2.23
Chromatin architecture near a potential 3' end of the igh locus involves modular regulation of histone modifications during B-Cell development and in vivo occupancy at CTCF sites. Mol Cell Biol (2005) 1.66
Replication and subnuclear location dynamics of the immunoglobulin heavy-chain locus in B-lineage cells. Mol Cell Biol (2002) 1.59
Linker histone H1 is essential for Drosophila development, the establishment of pericentric heterochromatin, and a normal polytene chromosome structure. Genes Dev (2009) 1.50
Regulation of lymphoid versus myeloid fate 'choice' by the transcription factor Mef2c. Nat Immunol (2009) 1.49
The interaction of Pax5 (BSAP) with Daxx can result in transcriptional activation in B cells. J Biol Chem (2002) 1.31
Evidence for physical interaction between the immunoglobulin heavy chain variable region and the 3' regulatory region. J Biol Chem (2007) 1.23
Peyer's patch M cells derived from Lgr5(+) stem cells require SpiB and are induced by RankL in cultured "miniguts". Mol Cell Biol (2012) 1.21
The origin of a developmentally regulated Igh replicon is located near the border of regulatory domains for Igh replication and expression. Proc Natl Acad Sci U S A (2002) 1.16
A novel human Ada2 homologue functions with Gcn5 or Brg1 to coactivate transcription. Mol Cell Biol (2003) 1.15
Drosophila H1 regulates the genetic activity of heterochromatin by recruitment of Su(var)3-9. Science (2013) 1.06
Regulation of the interleukin-7 receptor alpha promoter by the Ets transcription factors PU.1 and GA-binding protein in developing B cells. J Biol Chem (2007) 1.06
Analysis of gene expression and Ig transcription in PU.1/Spi-B-deficient progenitor B cell lines. J Immunol (2004) 1.04
Pax5 and linker histone H1 coordinate DNA methylation and histone modifications in the 3' regulatory region of the immunoglobulin heavy chain locus. Mol Cell Biol (2008) 0.99
The transcription factor PU.1 is a critical regulator of cellular communication in the immune system. Arch Immunol Ther Exp (Warsz) (2011) 0.99
Germline deletion of Igh 3' regulatory region elements hs 5, 6, 7 (hs5-7) affects B cell-specific regulation, rearrangement, and insulation of the Igh locus. J Immunol (2012) 0.97
Deletion of genes encoding PU.1 and Spi-B in B cells impairs differentiation and induces pre-B cell acute lymphoblastic leukemia. Blood (2011) 0.97
Analysis of concentration-dependent functions of PU.1 in hematopoiesis using mouse models. Blood Cells Mol Dis (2007) 0.97
The rate of epidemiological and virological changes during the transition from nascent to concentrated HIV epidemic stage in the former Soviet Union countries. AIDS Res Hum Retroviruses (2007) 0.94
NF-kappa B and Oct-2 synergize to activate the human 3' Igh hs4 enhancer in B cells. J Immunol (2004) 0.92
Homologous elements hs3a and hs3b in the 3' regulatory region of the murine immunoglobulin heavy chain (Igh) locus are both dispensable for class-switch recombination. J Biol Chem (2011) 0.91
Polymorphisms of the IgH enhancer HS1.2 and risk of systemic lupus erythematosus. Ann Rheum Dis (2012) 0.90
Reduction in PU.1 activity results in a block to B-cell development, abnormal myeloid proliferation, and neonatal lethality. Exp Hematol (2007) 0.89
Yin Yang 1 is a lipopolysaccharide-inducible activator of the murine 3' Igh enhancer, hs3. J Immunol (2003) 0.89
Dynamic changes in binding of immunoglobulin heavy chain 3' regulatory region to protein factors during class switching. J Biol Chem (2011) 0.89
Comparative analysis of human and mouse 3' Igh regulatory regions identifies distinctive structural features. Mol Immunol (2005) 0.88
PU.1 immortalizes hematopoietic progenitors in a GM-CSF-dependent manner. Exp Hematol (2007) 0.88
Elucidation of a downstream boundary of the 3' IgH regulatory region. Mol Immunol (2003) 0.86
Analysis of transcripts from 17p13.3 in medulloblastoma suggests ROX/MNT as a potential tumour suppressor gene. Eur J Cancer (2004) 0.85
Interaction between the immunoglobulin heavy chain 3' regulatory region and the IgH transcription unit during B cell differentiation. Mol Immunol (2011) 0.83
Regulation of B cell linker protein transcription by PU.1 and Spi-B in murine B cell acute lymphoblastic leukemia. J Immunol (2012) 0.83
Changes in replication, nuclear location, and expression of the Igh locus after fusion of a pre-B cell line with a T cell line. J Immunol (2005) 0.82
Treatment and awareness of type 2 diabetes in Beijing, China, compared to New York. Diabetes Educ (2007) 0.81
Transgenic expression of Spi-C impairs B-cell development and function by affecting genes associated with BCR signaling. Eur J Immunol (2008) 0.78
Optimization and application of a flow cytometric PU.1 assay for murine immune cells. J Immunol Methods (2012) 0.75